The Lead Poisoning Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for lead poisoning treatment has seen robust growth lately. In 2024, the market was valued at $5.78 billion and it is projected to rise to $6.09 billion in 2025, marking a compound annual growth rate (CAGR) of 5.4%.
The lead poisoning treatment market is forecasted to reach $7.46 billion in 2029 with a compound annual growth rate of 5.2%.
Download Your Free Sample of the 2025 Lead Poisoning Treatment Market Report and Uncover Key Trends Now!The key drivers in the lead poisoning treatment market are:
• Increase in global funding for lead exposure mitigation
• Rising awareness about the health impacts of lead toxicity
• Stricter government regulation on the usage of lead
• High prevalence of lead exposure in developing countries
The lead poisoning treatment market covered in this report is segmented –
1) By Treatment Type: Chelation Therapy, Contemporary Treatment, Supportive Care
2) By Route Of Administration: Oral, Intravenous, Intramuscular
3) By Patient Type: Pediatric, Adult, Geriatric
4) By End-User: Hospitals, Clinics, Homecare
The key trends in the lead poisoning treatment market are:
• The market is seeing a trend towards the integration of crown ether-based silicon photonics for accurate lead detection.
• The application of shock electrodialysis for efficient lead removal from water is a notable emerging trend.
• Widespread use of reverse osmosis and ion-exchange filtration technologies is also gaining momentum as an emerging trend.
• Advancement in AI-driven analytics for early detection and treatment planning, along with portable blood lead analyzers for rapid diagnostics, are shaping the future market.
Major players in the lead poisoning treatment market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• AbbVie Inc.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• GlaxoSmithKline (GSK) plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Bayer AG
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd
• Boehringer Ingelheim GmbH
• Sun Pharmaceutical Industries Ltd
• Bausch Health Companies Inc.
• Cipla Limited
• Dr. Reddy’s Laboratories Ltd.
• Lupin Pharmaceuticals Inc.
• Intelicure Lifesciences
• Recordati Rare Diseases Inc.
• Rising Pharmaceuticals
• Akorn Incorporated.
North America was the largest region in the lead poisoning treatment market in 2024